Akari Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Progress of AKTX-101 Towards Phase 1 and Strategic Collaboration for Its ADC Payload Platform
Globe Newswire•13/08/2026•16:15 ET
0
Whiz Insights
Get started
Create a free account to read the full story.